Speeding Up Malaria Vaccine Development


A recently announced follow-on collaboration between the PATH Malaria Vaccine Initiative (MVI) and Invovio Pharmaceuticals will test whether a novel vaccine approach that combines genetically engineered DNA with an innovative vaccine delivery technology could induce a human immune response that protects against malaria infection.

Mosquitoes

InFocus